EUVIMED · CrossrefJournal
New England Journal of Medicine
ISSN 0028-4793 · Massachusetts Medical Society
Frequent topics
HIV/AIDS epidemicpublic health policyHIVdrug overdoseheroinhistory of infectious disease controlhistory of public healthinfectious disease controlopioid epidemicopioid use disorderopioid-related deathsoutbreak response
Latest articles
Revertant Autograft Replacement in Recessive Dystrophic Epidermolysis Bullosa
Enfortumab Vedotin and Pembrolizumab for Cisplatin-Eligible Bladder Cancer
Meningococcal B Vaccine to Prevent Gonorrhea
Case 33-2026: A 73-Year-Old Woman with Fever, Weight Loss, and Leg Weakness
Too Soon to Say Goodbye — Aspirin at the Door in STEMI
Slightly Alive — Improving Antituberculosis Therapy
Cutaneous Anthrax
Assessing Multiple Treatment Regimens for Tuberculosis
Closing the Gap
Acute Respiratory Distress Syndrome
Healing Health Care in Rural America — Toward Community-Centered Learning Health Systems
Semaglutide for the Treatment of Obesity in Children 6 to
Functional Fixed Dystonia of the Foot
What the Robot Still Can’t Do
The Unexamined Subsidy — Rethinking Incentives for Outpatient Clinical Preceptors
Reimagining Health Policy Research
Interferon-γ Underlying Thymoma-Associated Immune Dysregulation
Autoantibodies against Type I Interferons and Death from H7N7 Avian Influenza
Subretinal Gene Therapy in X-Linked Retinoschisis
Iptacopan in IgA Nephropathy — Final 24-Month Data
Perioperative Apalutamide in High-Risk Localized Prostate Cancer
Case 32-2026: A 50-Year-Old Man with Recurrent Cardiomyopathy
The Emerging Role of Treatment Policy Implementation Trials in Acute Coronary Syndrome
Aspirin Therapy — Enough after Arthroplasty?
Lung Hernia with a Chest-Wall Hematoma
Lung Hernia with a Chest-Wall Bulge
Prevention of Venous Thromboembolism after Total Hip or Knee Replacement
Rivaroxaban Then Aspirin vs. Aspirin Alone after Total Hip or Knee Arthroplasty
Ravulizumab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
Prasugrel versus Ticagrelor in Acute Coronary Syndromes
Volumes
2026 · 9972025 · 9952024 · 9982023 · 1,0742022 · 1,1242021 · 1,1292020 · 1,2702019 · 1,0812018 · 1,0862017 · 1,0812016 · 1,1112015 · 1,1112014 · 1,1242013 · 1,1532012 · 1,1832011 · 1,1952010 · 1,2452009 · 1,3402008 · 1,3152007 · 1,3632006 · 1,4072005 · 1,4372004 · 1,4392003 · 1,3542002 · 1,2332001 · 1,0842000 · 1,1341999 · 1,1811998 · 1,1411997 · 1,2131996 · 1,1831995 · 1,2391994 · 1,3481993 · 1,3831992 · 1,4251991 · 1,4141990 · 1,4961989 · 1,5031988 · 1,4741987 · 1,442
EUVIMED